ATE483458T1 - Einsatz von agomelatin zur herstellung von medikamenten zur behandlung von periventrikulärer leukomalazie - Google Patents

Einsatz von agomelatin zur herstellung von medikamenten zur behandlung von periventrikulärer leukomalazie

Info

Publication number
ATE483458T1
ATE483458T1 AT07291392T AT07291392T ATE483458T1 AT E483458 T1 ATE483458 T1 AT E483458T1 AT 07291392 T AT07291392 T AT 07291392T AT 07291392 T AT07291392 T AT 07291392T AT E483458 T1 ATE483458 T1 AT E483458T1
Authority
AT
Austria
Prior art keywords
agomelatin
medications
treatment
production
periventricular leukomalacia
Prior art date
Application number
AT07291392T
Other languages
English (en)
Inventor
Michael Spedding
Elisabeth Mocaer
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38229589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE483458(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of ATE483458T1 publication Critical patent/ATE483458T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07291392T 2006-11-24 2007-11-23 Einsatz von agomelatin zur herstellung von medikamenten zur behandlung von periventrikulärer leukomalazie ATE483458T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0610294A FR2908994B1 (fr) 2006-11-24 2006-11-24 Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement de la leucomalacie periventriculaire

Publications (1)

Publication Number Publication Date
ATE483458T1 true ATE483458T1 (de) 2010-10-15

Family

ID=38229589

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07291392T ATE483458T1 (de) 2006-11-24 2007-11-23 Einsatz von agomelatin zur herstellung von medikamenten zur behandlung von periventrikulärer leukomalazie

Country Status (37)

Country Link
US (1) US20080125493A1 (de)
EP (1) EP1927351B1 (de)
JP (1) JP4870062B2 (de)
KR (1) KR100976000B1 (de)
CN (1) CN101185644B (de)
AR (1) AR063895A1 (de)
AT (1) ATE483458T1 (de)
AU (1) AU2007234600B2 (de)
BR (1) BRPI0704179A (de)
CA (1) CA2610637C (de)
CL (1) CL2007003395A1 (de)
CY (1) CY1110875T1 (de)
DE (1) DE602007009627D1 (de)
DK (1) DK1927351T3 (de)
EA (1) EA014067B1 (de)
ES (1) ES2353128T3 (de)
FR (1) FR2908994B1 (de)
GE (1) GEP20094747B (de)
HR (1) HRP20100680T1 (de)
JO (1) JO2631B1 (de)
MA (1) MA29522B1 (de)
ME (1) ME01866B (de)
MX (1) MX2007014004A (de)
MY (1) MY145925A (de)
NO (1) NO338598B1 (de)
NZ (1) NZ563683A (de)
PE (1) PE20081158A1 (de)
PL (1) PL1927351T3 (de)
PT (1) PT1927351E (de)
RS (1) RS51494B (de)
SG (1) SG143202A1 (de)
SI (1) SI1927351T1 (de)
TW (1) TW200829236A (de)
UA (1) UA94043C2 (de)
UY (1) UY30703A1 (de)
WO (1) WO2008071869A2 (de)
ZA (1) ZA200710102B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE036989T2 (hu) 2013-06-06 2018-08-28 Zentiva Ks Agomelatin készítmény, amely agomelatint ko-kristály formájában tartalmaz
EP2810647A1 (de) * 2013-06-06 2014-12-10 Zentiva, a.s. Pharmazeutische Formulierungen, enthaltend Agomelatin in der Form des Co-Kristalls von Agomelatin mit organischer Säure

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US6921775B2 (en) * 2001-08-03 2005-07-26 Children's Medical Center Corporation Methods for modulating brain damage
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
US7358395B2 (en) * 2005-08-03 2008-04-15 Les Laboratories Servier Crystalline form V of agomelatine, a process for its preparation and pharmaceutical compositions containing it

Also Published As

Publication number Publication date
EP1927351B1 (de) 2010-10-06
EA200702317A1 (ru) 2008-06-30
JP2008133279A (ja) 2008-06-12
CY1110875T1 (el) 2015-06-10
JP4870062B2 (ja) 2012-02-08
SI1927351T1 (sl) 2010-12-31
HK1118216A1 (en) 2009-02-06
TW200829236A (en) 2008-07-16
EP1927351A1 (de) 2008-06-04
NO20076002L (no) 2008-05-26
HRP20100680T1 (hr) 2011-01-31
AU2007234600A1 (en) 2008-06-12
NZ563683A (en) 2009-04-30
UY30703A1 (es) 2008-01-02
AU2007234600B2 (en) 2012-05-17
KR100976000B1 (ko) 2010-08-17
ME01866B (me) 2011-04-30
DK1927351T3 (da) 2011-01-10
BRPI0704179A (pt) 2008-07-08
MA29522B1 (fr) 2008-06-02
WO2008071869A3 (fr) 2008-08-14
NO338598B1 (no) 2016-09-12
SG143202A1 (en) 2008-06-27
UA94043C2 (ru) 2011-04-11
ZA200710102B (en) 2008-11-26
KR20080047298A (ko) 2008-05-28
AR063895A1 (es) 2009-02-25
GEP20094747B (en) 2009-07-27
CN101185644B (zh) 2011-08-10
US20080125493A1 (en) 2008-05-29
RS51494B (sr) 2011-04-30
PE20081158A1 (es) 2008-10-04
PL1927351T3 (pl) 2011-01-31
AU2007234600A8 (en) 2010-12-02
CA2610637A1 (fr) 2008-05-24
CA2610637C (fr) 2011-04-19
WO2008071869A2 (fr) 2008-06-19
FR2908994A1 (fr) 2008-05-30
PT1927351E (pt) 2010-10-27
FR2908994B1 (fr) 2009-04-03
MY145925A (en) 2012-05-15
MX2007014004A (es) 2009-02-16
CL2007003395A1 (es) 2008-09-12
CN101185644A (zh) 2008-05-28
JO2631B1 (en) 2012-06-17
EA014067B1 (ru) 2010-08-30
ES2353128T3 (es) 2011-02-25
DE602007009627D1 (de) 2010-11-18

Similar Documents

Publication Publication Date Title
EP1981526A4 (de) Adiponectin zur behandlung verschiedener erkrankungen
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
EP3861968C0 (de) Vorrichtungen zur behandlung von schlafapnoe
DE602006019838D1 (de) Piperazinsubstituierte benzothiophene zur behandlung von geisteskrankheiten
HUS1600048I1 (hu) Készítmény Fabry-kór kezelésére
ATE533518T1 (de) Resorbierbare polyetherester zur herstellung von medizinischen implantaten
EP2021352A4 (de) Behandlung von protein-missfaltung
ATE550329T1 (de) Heterobicyclische sulfonamidderivate zur behandlung von diabetes
EP3895670C0 (de) Vorrichtung zur behandlung von adipositas
ATE522624T1 (de) Identifizierung von krankheitserregern
ATE430706T1 (de) Kapsel zur herstellung von getränken
EP2046315A4 (de) Therapeutische mittel zur behandlung maligner lymphome
ATE429218T1 (de) Pinolensäure zur behandlung von übergewicht
DE112008000701A5 (de) Zusammensetzung zur Herstellung von Speisern
EP2135858A4 (de) Zusammensetzung zur behandlung von infektionserkrankungen
ATE534633T1 (de) Indazolderivate zur behandlung von hsp90- induzierten krankheiten
ATE532507T1 (de) Neramexane zur behandlung von subakuten tinnitus
ATE477798T1 (de) Verwendung von agomelatin zur herstellung von medikamenten zur behandlung der generalisierten angststörung
EP3769718C0 (de) Vorrichtung zur behandlung von darmerkrankungen
EP2249765A4 (de) Dapson zur behandlung von rosascea
DE602008002968D1 (de) Gerät zur Herstellung von RFID-Etiketten
FI20095600L (fi) Koostumus ihosairauksien hoitoa varten
DE602006009764D1 (de) Terphenylderivate zur Alzheimerbehandlung
AT503967A3 (de) Vorrichtung zur herstellung von formteilen
DE602006009899D1 (de) Verwendung von oxycodon zur behandlung von viszeralem schmerz

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1927351

Country of ref document: EP